Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.87 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.87 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.58 |
| ▸ | ADH1B | P00325 | 2/20 | 0.57 |
| ▸ | ADH1C | P00326 | 2/20 | 0.57 |
| ▸ | ADH1A | P07327 | 2/20 | 0.57 |
| ▸ | ADH7 | P40394 | 2/20 | 0.57 |
| ▸ | ADH4 | P08319 | 1/20 | 0.57 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.56 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.56 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.56 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.56 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5313856 | 1.00 | TSHR (0.87) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL5165020 | 1.00 | TSHR (0.87) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL8980568 | 1.00 | TSHR (0.87) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL8980623 | 1.00 | TSHR (0.87) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL6545006 | 1.00 | TSHR (0.87) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL25210211 | 1.00 | TSHR (0.87) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL5502786 | 1.00 | TSHR (0.87) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL5500928 | 1.00 | TSHR (0.87) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL21611676 | 1.00 | TSHR (0.87) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL237903 | 1.00 | TSHR (0.87) | TSHRALDH1A1EPHX1ADH1BADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2797872-B1 | SULFIDE SCAVENGERS, METHODS FOR MAKING THEM AND METHODS FOR USING THEM | GEN ELECTRIC (US) | 2018-02-28 | — | — | EP | claimed |
| US-9108899-B2 | Sulfide scavengers, methods for making and methods for using | GENERAL ELECTRIC COMPANY (US) | 2015-08-18 | — | — | US | claimed |
| EP-2797872-A1 | SULFIDE SCAVENGERS, METHODS FOR MAKING AND METHODS FOR USING THEM | General Electric Company (US) | 2014-11-05 | — | — | EP | claimed |
| US-8530394-B2 | Sterically hindered N-methyl secondary and tertiary amine sulfur scavengers and methods for making and using same | CLEARWATER INTERNATIONAL LLC (US) | 2013-09-10 | — | — | US | claimed |
| US-20130172623-A1 | SULFIDE SCAVENGERS, METHODS FOR MAKING AND METHODS FOR USING | GENERAL ELECTRIC COMPANY (US) | 2013-07-04 | — | — | US | claimed |
| WO-2013101361-A1 | SULFIDE SCAVENGERS, METHODS FOR MAKING AND METHODS FOR USING THEM | GENERAL ELECTRIC COMPANY (US) | 2013-07-04 | — | — | WO | claimed |
| US-20090250659-A1 | STERICALLY HINDERED N-METHYL SECONDARY AND TERTIARY AMINE SULFUR SCAVENGERS AND METHODS FOR MAKING AND USING SAME | CLEARWATER INTERNATIONAL, LLC (US) | 2009-10-08 | — | — | US | claimed |
| US-7563929-B2 | Alkylation of N′-phenyl-N-alkylphenylenediamines in ionic liquid and N′-phenyl-N-alkyl(alkylphenylene) diamines produced thereby | CHEMTURA CORPORATION (US) | 2009-07-21 | — | — | US | claimed |
| US-20080234517-A1 | ALKYLATION OF N'-PHENYL-N-ALKYLPHENYLENEDIAMINES IN IONIC LIQUID AND N'-PHENYL-N-ALKYL(ALKYLPHENYLENE) DIAMINES PRODUCED THEREBY | CHEMTURA CORPORATION (US) | 2008-09-25 | — | — | US | claimed |
| US-20050153846-A1 | Sterically hindered N-methylsecondary and tertiary amine sulfur scavengers and methods for making and using same | WEATHERFORD/LAMB, INC. | 2005-07-14 | — | — | US | claimed |
| WO-2024091918-A2 | METHODS OF LIPID NANOPARTICLE PRODUCTION IN CROSS-MIXERS | MODERNATX, INC. (US) | 2024-05-02 | — | — | WO | disclosed |
| US-20220134131-A1 | ENERGY AUGMENTATION STRUCTURES FOR MEASURING AND THERAPEUTIC USES | IMMUNOLIGHT, LLC (US) | 2022-05-05 | — | — | US | disclosed |
| CN-111868842-B | Conductive paste with stable viscosity over time | 株式会社则武 | 2021-11-19 | — | — | CN | disclosed |
| WO-2021214204-A1 | RNA CONSTRUCTS AND USES THEREOF | BioNTech SE (DE) | 2021-10-28 | — | — | WO | disclosed |
| US-11059922-B2 | Method for cross-linking polymers | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2021-07-13 | — | — | US | disclosed |
| EP-0838508-A2 | Aqueous ink composition for use in an ink-jet printer | SEIKO EPSON CORPORATION (JP) | 1998-04-29 | — | — | EP | disclosed |
| US-5688823-A | ANTILIPEMIC AGENTS, ANTIGLYCEMIC AGENTS, OBESITY, GLUCOSE TOLERANCE INSUFFICIENCY, INSULIN RESISTANCE AND DIABETIC COMPLICATIONS | SANKYO COMPANY, LIMITED (JP) | 1997-11-18 | — | — | US | disclosed |
| US-5578620-A | TREATMENT OF DIABETES AND HYPERLIPEMIA | SANKYO COMPANY, LIMITED (JP) | 1996-11-26 | — | — | US | disclosed |
| EP-0678511-A2 | Thiazolidine and oxazolidine derivatives, their preparation and their medical use | SANKYO COMPANY LIMITED (JP) | 1995-10-25 | — | — | EP | disclosed |
| US-4992150-A | Telomer with alpha-olefin;oil and fuel additive | NIPPON OIL CO, LTD. (JP) | 1991-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234517-A1 | ALKYLATION OF N'-PHENYL-N-ALKYLPHENYLENEDIAMINES IN IONIC LIQUID AND N'-PHENYL-N-ALKYL(ALKYLPHENYLENE) DIAMINES PRODUCED THEREBY | PNMT, PNN, INMT | TSHR 3548/4885ALDH1A1 1010/4885EPHX1 3180/4885 |
| US-20220134131-A1 | ENERGY AUGMENTATION STRUCTURES FOR MEASURING AND THERAPEUTIC USES | GFM1, ETFA, TFAM | TSHR 1596/4885ALDH1A1 947/4885EPHX1 1621/4885 |
| US-20130172623-A1 | SULFIDE SCAVENGERS, METHODS FOR MAKING AND METHODS FOR USING | CBS, TST, GSS | TSHR 3439/4885ALDH1A1 133/4885EPHX1 1408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.